Tag
Peeyush Kumar Aggarwal
2 articles
MPS Pharmaa Q2 FY27 Reports Zero Revenue, ₹16.5L Loss
Board approved Q2 FY27 standalone results showing zero operational revenue and a net loss of ₹16.50 lakhs.
Company's drug manufacturing licenses are under renewal with FDA; operations suspended pendin
Interworld Digital Q2 FY27 Net Loss of ₹6.96 Lakh
Board approved Q2 FY27 unaudited standalone results, reporting a net loss of ₹6.96 lakh for the quarter.
Auditors issued a qualified review report citing no revenue, pending ROC fee litigation, and st